"10.1371_journal.pone.0043313","plos one","2012-08-15T00:00:00Z","Carlos Zgheib; Mazen Kurdi; Fouad A Zouein; Barak W Gunter; Brian A Stanley; Joe Zgheib; Damian G Romero; S Bruce King; Nazareno Paolocci; George W Booz","Departments of Pharmacology and Toxicology, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America; Department of Chemistry and Biochemistry, Faculty of Sciences, Lebanese University, Rafic Hariri Educational Campus, Hadath, Lebanon; Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America; Department of Medicine, Division of Cardiology, Centre Hospitalier Universitaire de Nancy, Brabois, France; Department of Biochemistry, School of Medicine, and Center for Excellence in Cardiovascular-Renal Research, The University of Mississippi Medical Center, Jackson, Mississippi, United States of America; Department of Chemistry, Wake Forest University, Winston-Salem, North Carolina, United States of America; Clinical Medicine Department, Section of General Pathology, University of Perugia, Perugia, Italy","Conceived and designed the experiments: CZ FAZ MK GWB. Performed the experiments: CZ FAZ MK BWG BAS GWB. Analyzed the data: CZ FAZ MK BWG GWB. Contributed reagents/materials/analysis tools: JZ SBK NP DGR GWB. Wrote the paper: CZ MK FAZ JZ NP BAS GWB.","The authors have read the journals policy and have the following conflict: Nazareno Paolocci is a founder and stock holder of Cardioxyl Pharmaceuticals Inc. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","08","Carlos Zgheib","CZ",10,TRUE,4,6,5,7,TRUE,TRUE,FALSE,0,NA,FALSE
